The drug trastuzumab deruxtecan improves progression-free survival in HER2-positive breast cancer in 75.8% of patients. The results of the study, led by the International Breast Cancer Center and published in The New England Journal of Medicine, are “the most positive in history,” according to the authors.
–
Related posts:
The drug used for diabetes can be used against obesity
3 High Cholesterol Symptoms That Affect How You Walk
62% of the population in Bolivia have already received the first dose of the anticovid vaccine, acco...
Paraguayan student received the vaccine in Russia and regretted the mismanagement of Mario Abdo - Na...
:strip_icc():format(jpeg)/kly-media-production/medias/2841654/original/096329800_1561972203-tbc.jpg "Recognize Early, Here Are 5 Signs of Tuberculosis Lung Disease")
